FilingReader Intelligence
Cao Fei gains control of Hubei Jumpcan Pharmaceutical
July 31, 2025 at 09:11 AM UTC•By FilingReader AI
Cao Fei's tender offer for Hubei Jumpcan Pharmaceutical shares concluded with minimal uptake - only 16,300 of the 350.8 million shares sought were tendered at 24.85 yuan each.
Despite the low response, Cao Fei now directly and indirectly controls 56.07% of the pharmaceutical company's total share capital.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
SSE:600566•Shanghai Stock Exchange
News Alerts
Get instant email alerts when Hubei Jumpcan Pharmaceutical publishes news
Free account required • Unsubscribe anytime